News

Study Reports Rare Case of Non-small Cell Lung Cancer in Patient with LEMS and Paraneoplastic Cerebellar Degeneration

A rare case of non-small cell lung cancer (NSCLC) was discovered in a patient with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome (PCD-LEMS) — the first report to link the cancer to late-onset PCD-LEMS, according to researchers. Their study, “Non-small cell lung cancer associated with late-onset Lambert–Eaton myasthenic syndrome…

Review Study Details Treatment Choices, Prognosis for LEMS

A study provided an overview of the use of amifampridine (brand names  Firdapse and the recently approved Ruzurgi), along with other treatment choices for Lambert-Eaton myasthenic syndrome, including those for resistant muscle weakness. The review study, “Recent Advances and Therapeutic Options in Lambert-Eaton Myasthenic Syndrome,” was published…

NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC

Next month’s annual conference of the National Organization for Rare Disorders (NORD) in Washington, D.C., couldn’t come at a better time, says Marshall Summar, MD, chairman of NORD’s board of directors. “The pace of discovery in rare diseases has gone from brisk to hypersonic,” Summar told BioNews Services, publisher…

Study Reports Rare Case of Tongue Muscle Atrophy in LEMS

A case report describes a rare event of tongue muscle atrophy (shrinkage) in a 48-year-old man with Lambert-Eaton myasthenic syndrome who also was diagnosed with small-cell lung cancer (SCLC). Following radiotherapy for the tumor, the patient fully recovered control of the tongue. The study, “Reversible tongue atrophy in Lambert-Eaton…